Worldwide Interstitial Cystitis Industry to 2030 - Insights, Epidemiology and Market Forecast - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Interstitial Cystitis (IC) - Market Insights, Epidemiology and Market Forecast - 2030" drug pipelines has been added to ResearchAndMarkets.com's offering.

This report delivers an in-depth understanding of the Interstitial Cystitis (IC), historical and forecasted epidemiology as well as the Interstitial Cystitis (IC) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Interstitial Cystitis (IC) market report provides current treatment practices, emerging drugs, and market share of the individual therapies, current and forecasted 7MM Interstitial Cystitis (IC) market size from 2017 to 2030. The report also covers current Interstitial Cystitis (IC) treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market.

Interstitial Cystitis (IC), also called as Painful Bladder Syndrome, is a chronic condition causing bladder pressure, bladder pain and sometimes pelvic pain. The pain ranges from mild discomfort to severe levels. Bladder is a hollow, muscular organ that stores urine. The bladder expands until it is full and then gives signals to the brain that it is time to urinate, communicating through the pelvic nerves. This creates the urge to urinate for most people. With IC, these signals get mixed up and then patients feel the need to urinate more often and with smaller volumes of urine than most people. The IC disease most often affects women and can have a long-lasting impact on the quality of life. Although there is no cure, medications and other therapies may offer some relief.

There are two type of IC such as Non-Ulcerative, which is found in 90% of the population suffering from Interstitial Cystitis. It is characterized by pinpoint hemorrhages called as glomerulations. Another types is Ulcerative, which comprises of about 5-10% of the patient population. . It is mainly characterized by Hunner's ulcers and the patches that bleed on bladder walls. Hunner's ulcers, also called Hunner's lesions or Hunner's patches, are a subtype of Interstitial Cystitis (also called IC) and are not ulcers in the usual sense. They are distinctive areas of inflammation on the bladder wall that characterize the classic form of IC. Hunner's ulcers are the one diagnostic feature that clinches the IC diagnosis, but this classic form of IC affects only about 5 to 10 percent of patients. Often, patients with this form of IC have more severe symptoms than patients with non-ulcerative IC.

The Interstitial Cystitis market report gives the thorough understanding of the IC by including details such as disease introduction, signs and symptoms, risk factors, causes, pathophysiology, biomarkers and diagnosis. It also provides treatment algorithms and treatment guidelines for AKI in the US, Europe, and Japan.

Key Topics Covered:

1. Key Insights
2. Interstitial Cystitis Market Overview at a Glance
3. Interstitial Cystitis (IC): Disease Background and Overview
4. Epidemiology and Patient Population
5. Country-Wise Epidemiology of Interstitial Cystitis Syndrome
6. Treatment Algorithm, Current Treatment, and Medical Practices
7. Recognized Establishments
8. Unmet Needs
9. Marketed Drugs
10. Instillations
11. Emerging Therapies
12. Interstitial Cystitis: 7 Major Market Analysis
13. The United States Market Outlook
14. EU-5 Countries: Market Outlook
15. Japan: Market Outlook
16. KOL Reviews
17. Case Reports
18. Market Drivers
19. Market Barriers
20. SWOT Analysis
21. Appendix
22. Publisher Capabilities
23. Disclaimer
24. About the Publisher
    

For more information about this drug pipelines report visit https://www.researchandmarkets.com/r/jo05dp